Home/Filings/4/0001209191-19-034413
4//SEC Filing

Raymond Brion S. 4

Accession 0001209191-19-034413

CIK 0001539029other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 5:13 PM ET

Size

5.1 KB

Accession

0001209191-19-034413

Insider Transaction Report

Form 4
Period: 2019-05-31
Raymond Brion S.
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2019-05-31+50,00050,000 total
Footnotes (1)
  • [F1]These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares underlying this restricted stock unit award will vest in full on May 31, 2020, subject to the Reporting Person's continuous service with the Issuer as of such vesting date, and subject to accelerated vesting in specified circumstances.

Issuer

Clearside Biomedical, Inc.

CIK 0001539029

Entity typeother

Related Parties

1
  • filerCIK 0001732744

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 5:13 PM ET
Size
5.1 KB